Chorioamnionitis in the Development of Cerebral Palsy: A Meta-analysis and Systematic Review

scientific article

Chorioamnionitis in the Development of Cerebral Palsy: A Meta-analysis and Systematic Review is …
instance of (P31):
scholarly articleQ13442814
meta-analysisQ815382

External links are
P356DOI10.1542/PEDS.2016-3781
P932PMC publication ID5470507
P698PubMed publication ID28814548

P50authorHenrik HagbergQ37370618
P2093author name stringLin Ma
Sidhartha Tan
Zhongjie Shi
Kehuan Luo
Sanjay Chawla
Girija Natarajan
Monika Bajaj
P2860cites workForest plots: trying to see the wood and the treesQ24525229
Risk factors for cerebral palsy in preterm infantsQ46527833
Placental lesions as predictors of cerebral palsy and abnormal neurocognitive function at school age in extremely low birth weight infants (<1 kg).Q47279472
Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infantsQ47281085
Prenatal events and the risk of cerebral palsy in very low birth weight infantsQ47293581
Population cohort associating chorioamnionitis, cord inflammatory cytokines and neurologic outcome in very preterm, extremely low birth weight infantsQ47348865
Histological chorioamnionitis is associated with cerebral palsy in preterm neonates.Q47644862
Prospective evaluation of perinatal risk factors for cerebral palsy and delayed development in high risk infantsQ48112783
Antecedents of cerebral palsy in a multicenter trial of indomethacin for intraventricular hemorrhageQ48695535
Prevalence of cerebral palsy: Autism and Developmental Disabilities Monitoring Network, three sites, United States, 2004.Q50344331
Chorioamnionitis and outcome in extremely preterm infants.Q50483054
Intrauterine infection, magnesium sulfate exposure and cerebral palsy in infants born between 26 and 30 weeks of gestation.Q51394133
Effect of chorioamnionitis on neurodevelopmental outcome in preterm infants.Q51924359
Antenatal steroids may reduce adverse neurological outcome following chorioamnionitis: neurodevelopmental outcome and chorioamnionitis in premature infants.Q51931421
Intrauterine infection with Ureaplasma species is associated with adverse neuromotor outcome at 1 and 2 years adjusted age in preterm infants.Q51947182
Risk factors for cerebral palsy in PPROM and preterm delivery with intact membranes (.).Q53165592
Children who "outgrew' cerebral palsyQ70355272
Cerebral palsyQ72666334
Survival and neonatal and neurodevelopmental outcome of 24-29 week gestation infants according to primary cause of preterm deliveryQ73509190
Intrauterine infection and the risk of cerebral palsy in very low-birthweight infantsQ74246478
Maternal antecedents for cerebral palsy in extremely preterm babies: a case-control studyQ74551614
Does peripartum infection increase the incidence of cerebral palsy in extremely low birthweight infants?Q80233404
Perinatal factors associated with the neurologic impairment of children born pretermQ81013339
Cerebral palsyQ89217011
Cerebral palsy and placental infection: a case-cohort studyQ24797190
Meta-analysis of Observational Studies in Epidemiology: A Proposal for ReportingQ27861077
Chorioamnionitis as a risk factor for cerebral palsy: A meta-analysisQ28138808
Funnel plots for detecting bias in meta-analysis: guidelines on choice of axisQ28189245
The gut microbiota shapes intestinal immune responses during health and diseaseQ29547727
Assessing heterogeneity in meta-analysis: Q statistic or I2 index?Q29619545
Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years.Q33896064
Risk of cerebral palsy in relation to pregnancy disorders and preterm birth: a national cohort studyQ33934526
Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003.Q34293420
Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsyQ34434035
Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates.Q34449153
Prenatal Factors in Singletons with Cerebral Palsy Born at or near TermQ34492064
Systematic review of chorioamnionitis and cerebral palsyQ34580881
Health care use and health and functional impact of developmental disabilities among US children, 1997-2005.Q34602674
Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a WorkshopQ34675647
Correlation between initial neonatal and early childhood outcomes following preterm birthQ34729090
Chorioamnionitis and cerebral palsy in term and near-term infantsQ35596413
Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significanceQ36640880
Maternal Infections During Pregnancy and Cerebral Palsy in the Child.Q36711767
Histological characteristics of the fetal inflammatory response associated with neurodevelopmental impairment and death in extremely preterm infantsQ37097791
Chorioamnionitis and cerebral palsy: a meta-analysisQ37776130
Neonatal cytokines and cerebral palsy in very preterm infantsQ38453235
Onset factors in cerebral palsy: A systematic review.Q38798495
Chorioamnionitis at birth does not increase the risk of neurodevelopmental disability in premature infants with bronchopulmonary dysplasiaQ39463263
Association of severe placental inflammation with death prior to discharge and cerebral palsy in preterm infants.Q39591742
Maternal infection and risk of cerebral palsy in term and preterm infantsQ40521296
Cerebral palsy in preterm infants: a population-based case-control study of antenatal and intrapartal risk factorsQ40575178
Maternal Infection and Cerebral Palsy in Infants of Normal Birth WeightQ40648005
Methods for exploring heterogeneity in meta-analysisQ40689559
Term maternal and neonatal complications of acute chorioamnionitisQ40816777
Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children.Q40848735
Long-term outcomes of antenatal corticosteroids treatment in very preterm infants after chorioamnionitisQ40922845
Cerebral palsy in very low birthweight infantsQ41199160
Clinical chorioamnionitis at term I: microbiology of the amniotic cavity using cultivation and molecular techniquesQ41462724
Impact of chorioamnionitis on short- and long-term outcomes in very low birth weight preterm infants: the Neonatal Research Network JapanQ41611607
Prevalence of cerebral palsy in twins, triplets and quadrupletsQ43619127
The relationship between placental and other perinatal risk factors for neurologic impairment in very low birth weight childrenQ44556351
The impact of clinical maternal chorioamnionitis on neurological and psychological sequelae in very-low-birth weight infants: a case-control studyQ44755512
Histological chorioamnionitis and neurodevelopmental outcome in preterm infants.Q46011545
Effect of clinical and histological chorioamnionitis on the outcome of preterm infantsQ46323384
Prenatal and perinatal factors in the etiology of cerebral palsyQ46388821
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectcerebral palsyQ210427
P577publication date2017-06-01
P1433published inPediatricsQ7159238
P1476titleChorioamnionitis in the Development of Cerebral Palsy: A Meta-analysis and Systematic Review
P478volume139

Reverse relations

cites work (P2860)
Q47899520Chorioamnionitis, IL-17A, and fetal origins of neurologic disease
Q98771393DNA Methylation Profile in Human Cord Blood Mononuclear Leukocytes From Term Neonates: Effects of Histological Chorioamnionitis
Q90288012Histological chorioamnionitis and developmental outcomes in very preterm infants
Q64234558Impact of different stages of intrauterine inflammation on outcome of preterm neonates: Gestational age-dependent and -independent effect
Q92088498Is chorioamnionitis associated with neurodevelopmental outcomes in preterm infants? A systematic review and meta-analysis following PRISMA
Q93132005Placental assessment provides insight into mechanisms and timing of neonatal hypoxic-ischemic encephalopathy

Search more.